| 1 |
34896968 | Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells. | 2022 Feb |
9 |
| 2 |
34982348 | Empagliflozin Ameliorates Ouabain-Induced Na+ and Ca2+ Dysregulations in Ventricular Myocytes in an Na+-Dependent Manner. | 2022 Jan 4 |
3 |
| 3 |
35177077 | Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics. | 2022 Feb 17 |
2 |
| 4 |
35334035 | Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression. | 2022 Jun |
2 |
| 5 |
32946200 | Empagliflozin inhibits Na+ /H+ exchanger activity in human atrial cardiomyocytes. | 2020 Sep 18 |
2 |